e-learning
resources
Berlin 2008
Monday, 06.10.2008
Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of pyrazinamide resistance on treatment results of multidrug-resistant tuberculosis cases in Aegean region, Turkey
G. Senol, M. Gayaf, I. Karasu, A. Ozsoz (Izmir, Turkey)
Source:
Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Session:
Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Session type:
Thematic Poster Session
Number:
2538
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Senol, M. Gayaf, I. Karasu, A. Ozsoz (Izmir, Turkey). Effect of pyrazinamide resistance on treatment results of multidrug-resistant tuberculosis cases in Aegean region, Turkey. Eur Respir J 2008; 32: Suppl. 52, 2538
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Pyrazinamide resistance in multidrug-resistant tuberculosis in Aegean region, Turkey
Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2008
High incidence of the Beijing strains among multi drug resistance isolates of Mycobacterium tuberculosis from extra pulmonary tuberculosis cases in northern India
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012
Frequency of multi-drug resistant M.tuberculosis and HLA-class-2 gene associations in tuberculosis patients in the Republic of Tuva
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I
Year: 2008
Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Treatment outcome of multi-drug resistant tuberculosis in Varanasi, India
Source: Eur Respir J 2002; 20: Suppl. 38, 615s
Year: 2002
The prevalence of pyrazinamide resistance in multidrug resistant tuberculosis cases in the Netherlands
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012
Emergence of drug resistance in
mycobacterium tuberculosis
isolates in Ibadan, Nigeria
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007
Detection of mutations associated with isoniazid and rifampicin resistance in
M. tuberculosis
isolates from Kazakhstan
Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis
Year: 2010
Genetic markers of multi-drug and extensive drug resistant M. tuberculosis in Kyrgyz Republic
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012
Resistance of Mycobacterium tuberculosis to the first-line (MDR) and second line (XDR) anti tuberculosis drugs in the south western zone of Nigeria: A- 3 year retrospective study
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk
Source: Eur Respir J 2012; 39: 1425-1431
Year: 2012
Increasing incidence of fluoroquinolone resistant tuberculosis in Bombay
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005
Study of drug resistance among untreated new cases of tuberculosis in Oran, Algeria
Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis
Year: 2008
Resistance profile of drugs composing the “shorter” regimen for multidrug-resistant tuberculosis in Brazil, 2000–2015
Source: Eur Respir J , 49 (4) 1602309; DOI: 10.1183/13993003.02309-2016
Year: 2017
Rapid genotypic assays for detection the rifampin and isoniazid resistance in
M. tuberculosis
strains and clinical specimens in Moldova
Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis
Year: 2010
Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia
Source: Eur Respir J 2012; 40: 133-142
Year: 2012
Treatment results in patients with XDR tuberculosis in Ukraine
Source: Eur Respir J 2007; 30: Suppl. 51, 272s
Year: 2007
Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015
XDR and MDR-TB genetic markers of M. tuberculosis strains circulating in Kyrgyz Republic
Source: Annual Congress 2011 - Challenges in tuberculosis control
Year: 2011
Multidrug resistance tuberculosis (MDR-TB) in the north east area of Tunisia
Source: Eur Respir J 2007; 30: Suppl. 51, 700s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept